logo
Plus   Neg
Share
Email

Recipharm Announces Terms Of Cash Offer For Consort Medical - Quick Facts

The boards of Recipharm AB, Recipharm Holdings Limited and Consort Medical plc have reached an agreement on the terms of a recommended cash offer to be made by Recipharm Holdings for the entire issued and to be issued share capital of Consort. Recipharm Holdings is a wholly-owned direct subsidiary of Recipharm AB.

Under the proposal, each Consort shareholder will be entitled to receive: for each Consort share 1,010 pence in cash. The proposed deal value the entire issued and to be issued ordinary share capital of Consort at approximately 505 million pounds on a fully diluted basis and implies an enterprise value of 627 million pounds.

The Consort Directors said they intend to recommend unanimously that Consort shareholders accept, or procure acceptance of, the offer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
eBay Inc. (EBAY) Wednesday reported a fourth-quarter profit that trumped Wall Street analysts' estimates, as did revenues. However, shares of the company slipped over 5% after the company issued a weak outlook for the first quarter. eBay's fourth-quarter profit dropped to $558 million or $0.69 per... Apple Inc. (AAPL) Wednesday reported a first-quarter profit that trumped Wall Street estimates, as the iPhone maker reported its "highest quarterly revenue ever" driven by strong demand for its iPhone 11 and 11 Pro models during the holiday season. The tech giant also issued a strong revenue outlook... New York Attorney General Letitia James has fled a lawsuit against Vyera Pharmaceuticals and two of its former CEOs, including imprisoned 'Pharma Bro' Martin Shkreli, for illegally monopolizing a life-saving drug Daraprim. The lawsuit seeks a lifetime ban on Shkreli and his business partner Kevin Mulleady working in the pharmaceutical industry.
RELATED NEWS
Follow RTT
>